{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:32:34Z","timestamp":1787758354739,"version":"build-2784847793"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hand, foot, and mouth disease (HFMD) remains a major public health concern among children in China, particularly in those under 5 years of age. Enterovirus 71 (EV71) is the leading cause of severe cases and mortality. Although EV71 vaccines are highly effective, they are currently self-paid in China, and evidence on publicly funded strategies remains limited. This study evaluated the health and economic impact of including the EV71 vaccine in the National Immunization Program (NIP) in Guangxi from a societal perspective, incorporating both direct medical costs and indirect productivity losses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A decision tree\u2013Markov model simulated a cohort of 420,000 newborns over a 5-year horizon. Two strategies were compared: NIP inclusion (free vaccination) and the current self-paid approach. Cost-effectiveness and cost\u2013benefit analyses were conducted, with outcomes including incremental cost-effectiveness ratio (ICER) and benefit\u2013cost ratio (BCR). Sensitivity analyses were performed to assess uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the self-paid strategy, NIP inclusion increased vaccination by 344,190 individuals and prevented 14,234 HFMD cases and 16 deaths. Disease-related costs decreased by USD 10.15 million, while vaccination costs increased by USD 19.71 million (BCR = 0.515). The intervention yielded 1,260.8 additional quality-adjusted life years (QALYs), with an ICER of USD 8,319.99\/QALY, approximately 1.005 times the per capita GDP of Guangxi, indicating acceptable cost-effectiveness. Vaccine price was the most influential parameter; reducing the price to USD 14.94 per dose would achieve cost\u2013benefit balance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Including the EV71 vaccine in the NIP would substantially reduce HFMD burden and is cost-effective. Price reductions could further improve economic outcomes and enable net societal benefits, supporting policy decisions in China and similar settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1842766","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:39:15Z","timestamp":1782711555000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Economic evaluation of including the EV71 vaccine in the national immunization program: a modeling study in Guangxi, China"],"prefix":"10.3389","volume":"14","author":[{"given":"Quan","family":"He","sequence":"first","affiliation":[{"name":"School of Public Health and Management, Guangxi University of Traditional Chinese Medicine","place":["Nanning, China"]},{"name":"Key Laboratory of Integrated Traditional Chinese and Western Medicine Translational Medicine for High Incidence Infectious Diseases in Guangxi","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Liao","sequence":"additional","affiliation":[{"name":"School of Public Health and Management, Guangxi University of Traditional Chinese Medicine","place":["Nanning, China"]},{"name":"Key Laboratory of Integrated Traditional Chinese and Western Medicine Translational Medicine for High Incidence Infectious Diseases in Guangxi","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Deng","sequence":"additional","affiliation":[{"name":"Sterile Supply Department, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqin","family":"Su","sequence":"additional","affiliation":[{"name":"School of Public Health and Management, Guangxi University of Traditional Chinese Medicine","place":["Nanning, China"]},{"name":"Key Laboratory of Integrated Traditional Chinese and Western Medicine Translational Medicine for High Incidence Infectious Diseases in Guangxi","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Immunization Planning Institute, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Mo","sequence":"additional","affiliation":[{"name":"Vaccine Clinical Research Institute, Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zou","sequence":"additional","affiliation":[{"name":"The Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Liuzhou Maternal and Child Health Hospital","place":["Liuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Liuzhou Maternal and Child Health Hospital","place":["Liuzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitong","family":"He","sequence":"additional","affiliation":[{"name":"Yulin Maternal and Child Health Hospital","place":["Yulin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Wei","sequence":"additional","affiliation":[{"name":"Development Planning Department, Guangxi University of Traditional Chinese Medicine","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[{"name":"School of Public Health and Management, Guangxi University of Traditional Chinese Medicine","place":["Nanning, China"]},{"name":"Key Laboratory of Integrated Traditional Chinese and Western Medicine Translational Medicine for High Incidence Infectious Diseases in Guangxi","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2307\/j.ctv1gt945c.22","article-title":"Epidemiological characteristics of hand, foot, and mouth disease in Yunnan Province, China, 2008\u20132019","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B2","unstructured":"Enterovirus 71 Vaccine Standardization"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/jphe.2019.11.02","article-title":"Effectiveness of the inactivated enterovirus 71 vaccine in children aged 6\u201335 months: protocol for a multicentre, case-control phase IV clinical trial","volume":"3","author":"Jin","year":"2019","journal-title":"J Public Health Emerg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.idm.2023.09.001","article-title":"The impact of EV71 vaccination program on hand, foot and mouth disease in Zhejiang Province, China: a negative control study","volume":"8","author":"Zheng","year":"2023","journal-title":"Infect Dis Model."},{"key":"B5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3760\/cma.j.cn112338-20220811-00704","article-title":"Analysis of the vaccination status of enterovirus type 71 inactivated vaccine in China from 2017 to 2021","volume":"44","author":"Zhang","year":"2023","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1186\/s12889-019-7619-y","article-title":"Spatial-temporal variation and risk factor analysis of hand, foot, and mouth disease in children under 5 years old in Guangxi, China","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Public Health."},{"key":"B7","volume-title":"Guangxi Statistical Yearbook 2024","year":"2024"},{"key":"B8","year":"2025","journal-title":"Statistical Communiqu\u00e9 on the 2024 National Economic and Social Development of Guangxi"},{"key":"B9","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"B11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med Decis Making."},{"key":"B12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/hec.770","article-title":"Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation","volume":"12","author":"Karnon","year":"2003","journal-title":"Health Econ."},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781139506779","volume-title":"Decision Making in Health and Medicine: Integrating Evidence and Values","author":"Hunink","year":"2014"},{"key":"B14","year":"2024","journal-title":"Statistical Communiqu\u00e9 on Health Services Development in Guangxi, 2024."},{"key":"B15","unstructured":"Average Annual Wage of Employees in Urban Units, 2024"},{"key":"B16","volume-title":"Transmission Dynamics of Hand, Foot and Mouth Disease and EV-A71 Serotype Patterns in Guangxi","author":"Zheng","year":"2022"},{"key":"B17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/22221751.2021.1901612","article-title":"Long-term neurodevelopment outcomes of hand, foot and mouth disease inpatients infected with EV-A71 or CV-A16","volume":"10","author":"Liang","year":"2021","journal-title":"Emerg Microbes Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmi.2019.06.029","article-title":"Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease","volume":"26","author":"Liu","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0184266","DOI":"10.1371\/journal.pone.0184266","article-title":"Economic costs and health-related quality of life for hand, foot and mouth disease (HFMD) patients in China","volume":"12","author":"Zheng","year":"2017","journal-title":"PLoS ONE."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e000442","DOI":"10.1136\/bmjgh-2017-000442","article-title":"Severity and burden of hand, foot and mouth disease in Asia: a modelling study","volume":"3","author":"Koh","year":"2018","journal-title":"BMJ Glob Health."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2049168","DOI":"10.1080\/21645515.2022.2049168","article-title":"Disease burden in patients with severe hand, foot and mouth disease in Jiangsu Province","volume":"18","author":"Han","year":"2022","journal-title":"Hum Vaccin Immunother."},{"key":"B22","volume-title":"WHO Guide for Standardization of Economic Evaluations of Immunization Programmes","year":"2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12916-021-02049-7","article-title":"National and provincial impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in China: a modeling analysis","volume":"19","author":"Zhang","year":"2021","journal-title":"BMC Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0005899","DOI":"10.1371\/journal.pntd.0005899","article-title":"Cost-effectiveness of a national enterovirus 71 vaccination program in China","volume":"11","author":"Wang","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1514501","DOI":"10.3389\/fpubh.2025.1514501","article-title":"Health economic evaluation of EV71 vaccination in children under the school-age population in Guangdong Province, China","volume":"13","author":"Zhang","year":"2025","journal-title":"Front Public Health."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1002013","DOI":"10.1371\/journal.pmed.1002013","article-title":"Routine pediatric enterovirus 71 vaccination in China: a cost-effectiveness analysis","volume":"13","author":"Wu","year":"2016","journal-title":"PLoS Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/vaccines12091028","article-title":"Effectiveness of EV-A71 vaccine and its impact on the incidence of hand, foot and mouth disease: a systematic review","volume":"12","author":"Hu","year":"2024","journal-title":"Vaccines."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0323782","DOI":"10.1371\/journal.pone.0323782","article-title":"The efficacy and effectiveness of enterovirus A71 vaccines against hand, foot and mouth disease: a systematic review and meta-analysis","volume":"20","author":"Yan","year":"2025","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmi.2024.09.020","article-title":"Effectiveness of the enterovirus A71 vaccine on hand, foot and mouth disease: A real-world study in China","volume":"31","author":"Liu","year":"2025","journal-title":"Clin Microbiol Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/S0140-6736(08)61365-3","article-title":"Emergence and control of infectious diseases in China","volume":"372","author":"Wang","year":"2008","journal-title":"Lancet."},{"key":"B32","unstructured":"Reply to proposal No\n          \n          Official Website of Hunan Provincial Medical Security Bureau\n          \n          2024"},{"key":"B33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vaccine.2012.10.103","article-title":"Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review","volume":"31","author":"Ozawa","year":"2012","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.19914\/j.CJVI.2024031","article-title":"Cost benefit analysis of incorporating 13 valent pneumococcal polysaccharide conjugate vaccine into Qinghai Province's immunization program based on decision tree Markov model","volume":"30","author":"Guo","year":"2024","journal-title":"Chin J Vaccines Immun"}],"updated-by":[{"DOI":"10.3389\/fpubh.2026.1951313","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000}}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1842766\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:08:34Z","timestamp":1787756914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1842766\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":34,"alternative-id":["10.3389\/fpubh.2026.1842766"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1842766","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1842766"}}